CN107184741A - Tabernaemontanus bulrush perfume compound external-use medicament and preparation method thereof - Google Patents

Tabernaemontanus bulrush perfume compound external-use medicament and preparation method thereof Download PDF

Info

Publication number
CN107184741A
CN107184741A CN201710497965.XA CN201710497965A CN107184741A CN 107184741 A CN107184741 A CN 107184741A CN 201710497965 A CN201710497965 A CN 201710497965A CN 107184741 A CN107184741 A CN 107184741A
Authority
CN
China
Prior art keywords
parts
tabernaemontanus bulrush
compound external
raw material
use medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201710497965.XA
Other languages
Chinese (zh)
Inventor
黄欧
黎小巨
陈小艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Zhengtang Group Ltd By Share Ltd
Original Assignee
Guangdong Zhengtang Group Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Zhengtang Group Ltd By Share Ltd filed Critical Guangdong Zhengtang Group Ltd By Share Ltd
Priority to CN201710497965.XA priority Critical patent/CN107184741A/en
Publication of CN107184741A publication Critical patent/CN107184741A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/83Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835Aquilaria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238Saposhnikovia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to Exterior-applied Chinese patent medicine technical field, more particularly to the fragrant compound external-use medicament of tabernaemontanus bulrush and preparation method thereof, the fragrant compound external-use medicament of tabernaemontanus bulrush of the invention includes the raw material of following parts by weight:50~90 parts of tabernaemontanus bulrush perfume (or spice), 40~75 parts of Cauliflower, 20~40 parts of the seed of cowherb, 30~60 parts of safflower, windproof 40~60 parts, 40~50 parts of calcined Dragon's bone, the topical agent being made through technical study, which has, to activate blood circulation and disperse blood clots, dispelling wind and eliminating dampness, clearing heat and detoxicating function, thoroughly osteoproliferation can be suppurated, stasis of blood productization water, and suction out outer drain into vitro, human body is not damaged through arm, muscle is recovered complete after suction is clean, few pain, do not influence body, do not influence work, so as to reach the purpose easily cured the disease, do not only reach that rapid-action and determined curative effect is lasting using drug therapy osteoproliferation of the present invention, difficulty in relapse after healing, and preferably promote the use of.

Description

Tabernaemontanus bulrush perfume compound external-use medicament and preparation method thereof
Technical field:
The present invention relates to Exterior-applied Chinese patent medicine technical field, more particularly to the fragrant compound external-use medicament of tabernaemontanus bulrush and preparation method thereof.
Background technology:
Osteoproliferation is a kind of current domestic and international extremely widespread difficult disease, seriously endangers the health of people, one is the course of disease The slow time is longer, and two be hurt like hell, and three be without good treatment method.Simply use acupuncture, massage, electro-ionic osmosis, medicine The physical therapies such as thing dialysis, magnetic therapy, closing, traction, cure the symptoms, not the disease, and do not reach the purpose of radical cure, and operation probably has sequelae again, Delay too long, aggravation, sharp ache, extremity numbness, activity can not be freely.
Osteoproliferation is, by osteoporosis decalcification, soft tissue retrogression, to be invaded outside by chill is wet in addition, machinery is worked, outside The combined causes such as wound, kidney deficiency, cause stagnation of QI-blood, multiple abscess with damp phlegm eventually forms arthrocele, spur, lip sample hyperplasia, and oppresses Nerve causes pain, numbness, activity not freely.According to the theory of the traditional Chinese medical science " bitterly then obstructed not ache by general rule ", no matter any portion of human body Pain, which occurs, in position to be all stagnation of QI-blood and causes, so the hyperplasia, protrusion, narrow that cervical vertebra, lumbar vertebrae, knee joint occur, mainly by Kidney deficiency, osteoporosis, decalcification and other inducements cause stagnation of QI-blood, and multiple abscess with damp phlegm forms epiphysis as hard as flint in the course of time It is attached on bone.
The sick symptom point cervical vertebra, lumbar vertebrae, knee joint, heel hyperplasia from position, there is osteoproliferation, intervertebral from symptom Disk is protruded, spinal canal stenosis and spur.Because position is different, and symptom is also different, and symptom, which occurs, in cervical spondylopathy is:Neck activity It is dumb, stiff pain, it is impossible to rotate, traction shoulder arm upper limbs, pain numbness, it is impossible to praise, and with dizziness and nausea.Lumbar vertebrae with It is tired more so very then to change one's position, it is impossible to sitting and lying and upright based on pain, and it is numb to lower limb pain to draw hip joint, it is impossible to Bend and stretch stride and muscular atrophy.And traditional treatment osteoproliferation is typically to be treated using surgery excision, also has plenty of use Medicine is treated, but used medicine often has toxic side effect.
The content of the invention:
The purpose of the present invention provides a kind of using pure plant processing aiming at the deficiency that prior art is present Into, the fragrant compound external-use medicament of the tabernaemontanus bulrush that has no toxic side effect, have significant curative effect to osteoproliferation, while also providing outside the fragrant compound of this tabernaemontanus bulrush With the preparation method of medicament.
To achieve these goals, the technical solution adopted by the present invention is:
Tabernaemontanus bulrush perfume compound external-use medicament, includes the raw material of following parts by weight:50~90 parts of tabernaemontanus bulrush perfume (or spice), 40~75 parts of Cauliflower, king 20~40 parts of row, 30~60 parts of safflower, windproof 40~60 parts, 40~50 parts of calcined Dragon's bone are not stayed.
Preferably, the fragrant compound external-use medicament of tabernaemontanus bulrush includes the raw material of following parts by weight:60~80 parts of tabernaemontanus bulrush perfume (or spice), Cauliflower 50~65 Part, 30~35 parts of the seed of cowherb, 40~50 parts of safflower, windproof 45~50 parts, calcined Dragon's bone 45~48.
The present invention also provides the preparation method of the fragrant compound external-use medicament of tabernaemontanus bulrush, comprises the following steps:
A, by parts by weight be 50~90 parts of tabernaemontanus bulrush perfume (or spice), 40~75 parts of Cauliflower, 20~40 parts of the seed of cowherb, safflower 30~60 Part, windproof 40~60 parts, the fresh herbal raw material wash clean of 40~50 parts of calcined Dragon's bone, and dry;
B, will dry after each herbal raw material be put into mortar grind, be homogenously mixed together each herbal raw material.
Beneficial effect of the present invention is:The fragrant compound external-use medicament of the tabernaemontanus bulrush of the present invention includes the raw material of following parts by weight:Tabernaemontanus bulrush is fragrant 50~90 parts, 40~75 parts of Cauliflower, 20~40 parts of the seed of cowherb, 30~60 parts of safflower, windproof 40~60 parts, calcined Dragon's bone 40~ 50 parts, the topical agent being made through technical study have activate blood circulation and disperse blood clots, dispelling wind and eliminating dampness, clearing heat and detoxicating function, can be thoroughly by bone The suppuration of matter hyperplasia, stasis of blood productization water, and sucking-off are outer to be drained into vitro, and human body is not damaged through arm, and the clean rear muscle recovery of suction is complete, pole Lack pain, body is not influenceed, work is not influenceed, so that the purpose easily cured the disease is reached, using drug therapy hyperostosis of the present invention It is raw not only reach rapid-action and determined curative effect persistently, difficulty in relapse after healing, and preferably promote the use of.
Embodiment:
Embodiment 1
Tabernaemontanus bulrush perfume compound external-use medicament, includes the raw material of following parts by weight:Tabernaemontanus bulrush is fragrant 50 parts, 75 parts of Cauliflower, the seed of cowherb 40 Part, 60 parts of safflower, windproof 60 parts, 50 parts of calcined Dragon's bone.
The present invention also provides the preparation method of the fragrant compound external-use medicament of tabernaemontanus bulrush, comprises the following steps:
A, by the tabernaemontanus bulrush perfume of above-mentioned parts by weight, Cauliflower, the seed of cowherb, safflower, windproof, calcined Dragon's bone fresh herbal raw material Wash clean, and dry;
B, will dry after each herbal raw material be put into mortar grind, be homogenously mixed together each herbal raw material.
The topical agent that is made through technical study of the present invention have activate blood circulation and disperse blood clots, dispelling wind and eliminating dampness, clearing heat and detoxicating function, energy Thoroughly osteoproliferation is suppurated, stasis of blood productization water, and suction out it is outer drain into external, human body is not damaged through arm, muscle is received after suction is clean It is multiple complete, few pain, body is not influenceed, work is not influenceed, so as to reach the purpose easily cured the disease, controlled using medicine of the present invention Treat osteoproliferation and do not only reach rapid-action and determined curative effect persistently, difficulty in relapse after healing, and preferably promote the use of.
Embodiment 2
Tabernaemontanus bulrush perfume compound external-use medicament, includes the raw material of following parts by weight:Tabernaemontanus bulrush is fragrant 90 parts, 75 parts of Cauliflower, the seed of cowherb 20 Part, 30 parts of safflower, windproof 40 parts, 50 parts of calcined Dragon's bone.Preparation method be the same as Example 1.
Embodiment 3
Tabernaemontanus bulrush perfume compound external-use medicament, includes the raw material of following parts by weight:Tabernaemontanus bulrush is fragrant 70 parts, 60 parts of Cauliflower, the seed of cowherb 30 Part, 45 parts of safflower, windproof 50 parts, 45 parts of calcined Dragon's bone.Preparation method be the same as Example 1.
Embodiment 4
Tabernaemontanus bulrush perfume compound external-use medicament, includes the raw material of following parts by weight:Tabernaemontanus bulrush is fragrant 80 parts, 50 parts of Cauliflower, the seed of cowherb 40 Part, 60 parts of safflower, windproof 50 parts, 43 parts of calcined Dragon's bone.Preparation method be the same as Example 1.
Embodiment 5
Tabernaemontanus bulrush perfume compound external-use medicament, includes the raw material of following parts by weight:Tabernaemontanus bulrush is fragrant 65 parts, 70 parts of Cauliflower, the seed of cowherb 25 Part, 40 parts of safflower, windproof 55 parts, 40 parts of calcined Dragon's bone.Preparation method be the same as Example 1.
Embodiment 6
Tabernaemontanus bulrush perfume compound external-use medicament, includes the raw material of following parts by weight:Tabernaemontanus bulrush is fragrant 90 parts, 40 parts of Cauliflower, the seed of cowherb 40 Part, 30 parts of safflower, windproof 60 parts, 40 parts of calcined Dragon's bone.Preparation method be the same as Example 1.
Certainly, described above is only presently preferred embodiments of the present invention, therefore all structures according to described in present patent application scope Make, the equivalent change or modification that feature and principle are done, be included in the range of present patent application.

Claims (3)

1. tabernaemontanus bulrush perfume compound external-use medicament, it is characterised in that include the raw material of following parts by weight:50~90 parts of tabernaemontanus bulrush perfume (or spice), Cauliflower 40 ~75 parts, 20~40 parts of the seed of cowherb, 30~60 parts of safflower, windproof 40~60 parts, 40~50 parts of calcined Dragon's bone.
2. the fragrant compound external-use medicament of tabernaemontanus bulrush according to claim 1, it is characterised in that include the raw material of following parts by weight:Tabernaemontanus bulrush It is fragrant 60~80 parts, 50~65 parts of Cauliflower, 30~35 parts of the seed of cowherb, 40~50 parts of safflower, windproof 45~50 parts, calcined Dragon's bone 45 ~48.
3. the preparation method of tabernaemontanus bulrush perfume compound external-use medicament, it is characterised in that:Comprise the following steps:
A, by parts by weight be 50~90 parts of tabernaemontanus bulrush perfume (or spice), 40~75 parts of Cauliflower, 20~40 parts of the seed of cowherb, 30~60 parts of safflower, prevent 40~60 parts of wind, the fresh herbal raw material wash clean of 40~50 parts of calcined Dragon's bone, and dry;
B, will dry after each herbal raw material be put into mortar grind, be homogenously mixed together each herbal raw material.
CN201710497965.XA 2017-06-27 2017-06-27 Tabernaemontanus bulrush perfume compound external-use medicament and preparation method thereof Withdrawn CN107184741A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710497965.XA CN107184741A (en) 2017-06-27 2017-06-27 Tabernaemontanus bulrush perfume compound external-use medicament and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710497965.XA CN107184741A (en) 2017-06-27 2017-06-27 Tabernaemontanus bulrush perfume compound external-use medicament and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107184741A true CN107184741A (en) 2017-09-22

Family

ID=59879976

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710497965.XA Withdrawn CN107184741A (en) 2017-06-27 2017-06-27 Tabernaemontanus bulrush perfume compound external-use medicament and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107184741A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102028788A (en) * 2010-12-23 2011-04-27 陈松标 External paste for treating osteoproliferation and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102028788A (en) * 2010-12-23 2011-04-27 陈松标 External paste for treating osteoproliferation and preparation method thereof

Similar Documents

Publication Publication Date Title
CN100571770C (en) A kind of Chinese medicine cutaneous permeable agent
CN105213986A (en) A kind of for neck shoulder, lumbar vertebra pain and rheumatism, arthralgic AIYAN physiotherapy bag
CN102429956A (en) External wash and use method thereof
CN103893702A (en) Traditional Chinese medicine composition for treating cervical spine bone hyperplasia and preparation method thereof
CN105982976A (en) Osteal penetrant for treating osteoarticular diseases and preparation method thereof
CN109589395A (en) A kind of stone acupuncture needle curve shoulder nourishing health composition
CN107184741A (en) Tabernaemontanus bulrush perfume compound external-use medicament and preparation method thereof
CN104107279A (en) Traditional Chinese medicament for treating lumbar disc herniation
CN1795905A (en) Medication for treating hyperosteogeny and complicating disease
CN102512570A (en) Chinese herbal medicine for treating rheumatism
CN102100759A (en) Traditional Chinese medicine composition with functions of tonifying liver and kidney and treating hyperosteogeny
CN101554435B (en) Traditional chinese medicine tea
CN104524128A (en) Traditional Chinese medicine composition treating cold blood stasis type scleroderma
CN101690750B (en) External medicine for curing hyperosteogeny
CN107334883A (en) A kind of Chinese medicine for treating protrusion of lumber intervertebral disc and cervical vertebrae hyperosteogeny and preparation method thereof
CN106038896A (en) Bonesetting pain relieving plaster applied to therapy and preparation method of bonesetting pain therapy herb plaster
CN104971219A (en) Traditional Chinese medicine prescription for treating rheumatic bone pain and preparation method of traditional Chinese medicine prescription
CN104055968A (en) Aerosol with effects of promoting blood circulation to remove meridian obstruction for postoperative patients
CN112043772A (en) Chinese medicine for treating various diseases
CN104189248A (en) Spilanthes paniculata tea with swelling and pain relieving effects and production method of spilanthes paniculata tea
CN104645067A (en) Traditional Chinese medicine for treating gonarthromeningitis by matching with acupuncture and moxibustion
CN105267323A (en) Cervical spondylosis treating formula
CN110251600A (en) A kind of bone health Chinese medicine and preparation method thereof
CN103690857A (en) Herbal medicine footbath powder for treating rheumatism
CN103495150A (en) Detoxification and tissue regeneration promoting foot bathing powder

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170922